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Abstract 
Background: Few centres and cardiac surgeons in the U.S. perform enough off-pump coronary 
artery bypass (OPCAB) procedures to be considered ‘‘specialists’’. The clinical implications 
of this observation remain unclear. We investigated whether the volume of OPCAB procedures 
by hospital and individual surgeon influenced patient outcomes when compared with on pump 
coronary artery bypass (ONCAB) surgery. 
Methods: A total of 546,243 OPCAB (26.1%) and 1,547,851 ONCAB (73.9%) procedures 
performed from 2003 to 2011 and collected in the US Nationwide Inpatient Sample were 
included in the analysis. Hierarchical logistic regression models were used to compared 
OPCAB and ONCAB in the whole population and across OPCAB volume quartile groups to 
investigate the effect of hospital and surgeon procedures volume on early in hospital mortality.  
Results: In patients requiring 2 or more grafts, OPCAB compared with ONCAB was 
associated with increased risk-adjusted mortality when performed in low volume centres (<29 
cases/year) (OR; 1.32;95%CI 1.06-1.57) or by low volume surgeons (<19 cases/year) (OR 
1.26; 95%CI 1.02- 1.56). In high OPCAB volume centres (≥164cases/year) and surgeons (≥48 
cases/year), OPCAB  reduced mortality compared with ONCAB in cases requiring a  single 
graft (OR 0.66; 95%CI 0.49-0.89 and OR 0.33; 95%CI 0.22-0.47) or 2 or more grafts (OR 
0.82; 9%%CI0.66- 0.99 and OR 0.63; 95%CI 0.49- 0.81).     
Conclusions: OPCAB surgery in high volume hospitals and surgeons reduces mortality 
compared to ONCAB surgery.  OPCAB surgery by low volume centres and surgeons should 
be discouraged.   
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Introduction 
Controversy still remains whether on off-pump coronary artery bypass (OPCAB) grafting is 
superior to on-pump coronary artery bypass (ONCAB) surgery in terms of in-hospital 
outcomes [1-2]. Although several large clinical trials [3-5] and institutional reports have 
attempted to compare the safety and efficacy of both approaches [6-7], reported outcomes 
remain mixed [8]. Volume–outcome relationships within surgical practice results are well 
known [9-11]. Studies investigating volume at individual surgeon or hospital level are 
attractive to physicians and administrators because they allow for an intuitive measure of 
‘‘expertise’’ and a proxy of enhanced safety and quality. It has been suggested that programs 
with greater OPCAB experience may have better results than those that perform these 
procedures less frequently [12-13] but sparse and conflicting results have been reported [14-
16]. A recent report from the Society of Thoracic Surgeons (STS), showed that only a few 
cardiac surgeons and centres in the U.S. perform enough OPCAB procedures to be considered 
‘‘specialists’’ [17]. However, the clinical implications of this observation remain unknown 
with some author advocating that OPCAB should be abandoned [8]. We investigated wheatear 
OPCAB hospital and surgeon volume significantly influenced early in hospital mortality when 
compared with ONCAB in a large U.S. cohort.  
Methods 
Data sources 
Patient discharge records reported for in-hospital admissions from 2003 to 2011 included in 
the Nationwide Inpatient Sample (NIS) databases were evaluated. The NIS represents a 20% 
stratified random sample of all hospital discharges in the United States, and collection, 
validation, and maintenance of the datasets are performed by the Agency for Healthcare 
Research and Quality [18]. The NIS datasets represent the largest publicly available inpatient 
care databases within the United States. Each year the NIS captures patient discharges reported 
from approximately 1000 American Hospital Association centres. The NIS data use national 
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hospital survey strata to weight each of the participating hospitals. Weights are provided for 
each discharge record, allowing nationally representative study populations to be produced. 
Weill Cornell Medical College confirmed that institutional review board approval and 
informed consent were not required for this study because it uses a unidentified administrative 
database. 
Patients 
The study included discharge records from 999 hospital and 44 states in NIS datasets from 
2000 to 2010 that specifically reported unique hospital identifiers for the study time period 
with selected International Classification of Diseases, 9th Revision, Clinical Modification 
(ICD-9-CM) procedure and diagnostic codes. Discharge records for patients undergoing 
CABG procedures were identified using the following ICD-9-CM procedure codes: 30.10, 
36.11, 36.12, 36.13, 36.14, 36.15, or 36.16. The concomitant use of cardiopulmonary bypass 
(CPB) support was identified by records that also included the following ICD-9-CM procedure 
codes for bypass support: 39.61 or 39.66. Discharge records for patients with concomitant 
cardiac valve procedures (ICD-9-CM codes 35.20, 35.21, 35.22, 35.23, 35.24, 35.25, 35.26, 
35.27, 35.28, 35.11, 35.12, 35.13, 35.14) or other cardiotomy (ICD-9-CM code 37.11) for 
purposes other than CPB were excluded. Patient-level and hospital-level variables were 
included as baseline characteristics. The Agency for Healthcare Research and Quality’s 
comorbidity measures based on the Elixhauser method were used to identify comorbid 
conditions [19]. Hospital-level data elements were derived from the AHA Annual Survey 
Database.  
Outcomes measured 
The primary outcome was in-hospital all-cause mortality for the overall cohort of isolated 
CABG. Secondary outcome measures were length of stay and total costs.  
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Statistical analysis 
Patients were stratified into OPCAB and ONCAB cohorts for descriptive purposes. OPCAB 
hospital volume was determined by calculating the total number of isolated operations 
performed for each centre during the study period (2003-2011). OPCAB hospital volume was 
categorized into quartiles: low (<25th percentile), medium (25–49th percentile), high (50–74th 
percentile), and very high (≥75th percentile). OPCAB and ONCAB were compared in the 
whole population and across OPCAB hospital volume and surgeon quartile groups. Weighted 
values of patient-level observations were generated to produce a nationally representative 
estimate of the entire US population of hospitalized patients. Differences between categorical 
variables were tested using the Pearson's chi-square test (Rao & Scott adjustment), and 
differences between continuous variables were tested using the Student t test. P Value <0.05 
was considered significant. Two separate hierarchical regression models with the unique 
hospital identification number incorporated as random effects within the model were used [20]: 
model 1: clustering for centres + patient level variables including age, gender, race, elective 
admission and risk related to coexisting medical conditions + hospital-level variables such as 
hospital region, location teaching status, and bed size; model 2: model 1+ ONCAB hospital 
volume and year of surgery. The last two variables were forced into the model to correct final 
estimates for the influence of operative volume during ONCAB [9] and to account for potential 
variation in the quality of care during the study period [21]. Hierarchical mixed-effects logistic 
regression models were used for categorical dependent variables such as primary and 
secondary outcomes, and hierarchical mixed-effects linear regression models were used for 
continuous dependent variables such as cost of care and length of stay. Subgroup analysis on 
hospital mortality according to the number of grafts performed (1 versus ≥2 grafts) across 
hospital and surgeon volume quartiles was performed. The analysis was repeated according to 
individual surgeon OPCAB volume including cases that specifically reported unique physician 
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identifiers for the study time period. Categorical variables are expressed as a percentage of the 
group of origin. Continuous variables are reported as mean ± standard error. Odds ratios (OR) 
with a 95% confidence interval (CI) are used to report the results of logistic regression models. 
Reported probability values are 2-tailed and were considered statistically significant if <0.05. 
Data analyses were performed using R version 3.1.2 and survey package (T. Lumley 2014 
"survey: analysis of complex survey samples". R package version 3.30).  
Results 
OPCAB Hospital Volume analysis  
The study population consisted of 2,094,094 patients who underwent isolated CABG during 
the period 2003-2011 in 999 US centres. OPCAB and ONCAB procedures were performed in 
546,243 (26.1%) and 1,547,851 (73.9%) cases respectively (Figure 1). OPCAB hospital 
relative volume and hospital rate were extremely heterogeneous across the centres (Figure 2). 
Median OPCAB and ONCAB hospital volume per year was 82 (IQR: 29-164) and 308 (IQR 
145-569) procedures respectively. Patient-level and Hospital level variables distribution in the 
OPCAB and ONCAB groups is reported in Table 1. Overall, differences between the two 
groups were not clinically relevant and operated on both directions. The number of procedures 
involving a single graft only, were higher in the OPCAB group. An overview on unadjusted 
outcomes is summarized in Table 2. Table 3 shows risk-adjusted effect of OPCAB versus 
ONCAB on outcomes investigated across OPCAB hospital volume quartile. In centres 
performed less than 29 cases per year, OPCAB was associated with a significantly higher risk-
adjusted mortality, length of stay and overall costs. On the other hand, in centres performing 
≥164 cases per year, OPCAB was associated with a significant 20% relative risk reduction in 
mortality compared to ONCAB.   
OPCAB Surgeon Volume analysis 
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The unique physician identifiers were available only from 2003 to 2009 including a total of 
1,024,872 cases performed by 6,724 surgeons. OPCAB and ONCAB were performed in 
295,045 (28.8%) and 729,827 (71.2%) cases respectively. Median OPCAB and ONCAB 
surgeon volume per year was 19 (IQR 6-48) and 79 (IQR 30-153) procedures respectively.  
Risk-adjusted estimates showed that surgeons performing less than 48 OPCAB cases per years, 
had a higher risk adjusted hospital mortality, prolonged length of stay and total costs compared 
to ONCAB surgery.  On the other hand, for surgeon performing ≥48 OPCAB cases per year, 
OPCAB was associated with a significant 42% relative risk reduction in mortality and 
significantly reduced overall costs when compared with ONCAB surgery.  
Subgroup analysis according to number of grafts performed.  
In case requiring a single graft only, OPCAB compared with ONCAB did not increase 
mortality in low volume hospitals and surgeons. In high OPCAB volume hospitals and 
surgeons, single graft OPCAB was associated with a lower adjusted-risk mortality when 
compared to ONCAB (Table 5).     
Discussion 
Despite the initial enthusiasm regarding the potential benefit from OPCAB over ONCAB in 
improving hospital mortality [6,7], several randomized trials have failed to demonstrate its 
superiority [3-5] and others have reported poorer outcomes [3]. These trials have been 
criticized by those who believe that OPCAB increased technical complexity, hospital volume 
and surgeon experience plays a major role in determining outcomes [12,13]. In the ROOBY 
trial [3], participating surgeons were required to have previously performed 20 OPCAB 
procedures a lack of experience which could explain the worse composite outcomes at1 year 
in this group of patients. In the more recent CORONARY trial [4], surgeons were required to 
have performed more than 100 procedures in OPCAB and ONCAB., Patients undergoing 
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OPCAB required  less  transfusion, reoperation for perioperative bleeding, respiratory 
complications, and acute kidney injury than those undergoing ONCAB. In the GOPCABE 
study [5], where surgeons were required to be established experts in the performance of 
OPCAB with and an average of 514 procedures (median, 322) no significant differences 
between OPCAB and ONCAB were found. It should be noted that none of these trials had 
sufficient power to accurately assess clinically important differences in mortality. In fact, to 
provide a power of 80% to detect a 30% relative risk reduction in the rate of in-hospital 
mortality or stroke (~2%), the required total sample size would be  19,506. The  CORONARY, 
GOPCABE and ROOBY trials have randomly assigned 4,752, 2,539 and 2,203 patients 
respectively and therefore, they were largely underpowered to detect differences in mortality 
or stroke. Expertise in OPCAB by individual surgeon and hospital seems therefore, to be an 
important determinant of outcome.[17,22]. However, little has been previously published, and 
s with conflicting results reported [12-16].  
Large registries have the potential to overcome the limitation of underpowered randomized 
controlled trials in detecting differences in hard clinical end points such as mortality. The 
present risk-adjusted analysis on US Nationwide Inpatient Sample on a very large number of 
procedures provides important insight into the relative impact of OPCAB hospital and surgeon 
volume on outcomes. We found that OPCAB when performed in low volume centres and by 
low volume surgeons, was associated with significantly increased risk-adjusted mortality 
length of stay and overall costs compared with ONCAB surgery. On the contrary, OPCAB was 
associated with a lower risk adjusted mortality when performed in high volume hospital (≥164 
cases/year) and surgeons (≥48 cases/year). Subgroup analysis according to number of grafts 
performed suggested that single graft OPCAB is as safe as ONCAB even in low volume 
hospitals and surgeons. On the other hand single graft OPCAB in high volume hospitals and 
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surgeons was associated with a lower risk-adjusted mortality when compared to single ONCAB 
graft.  
It could be argued that patient selection bias not accounted by the present risk-adjusted model, 
might partially explain the increased mortality after OPCAB in case of low-volume (only high 
risk patients received OPCAB). However, the fact that, in low volume centres, single graft but 
not multiple graft OPCAB was as safe as ONCAB supports the hypothesis that the increased 
technical complexity particularly relevant in case of multiple OPCAB grafts has the potential 
to increase mortality and morbidity in a low volume setting [3]. Nevertheless, this result 
suggests that “sporadic” OPCAB practise  is unlikely to neutralize the excess of mortality 
compared to ONCAB in selected cases and therefore, this strategy seems questionable.  The 
reduced risk-adjusted mortality in patients undergoing OPCAB in a high volume hospital, ≥164 
cases/year) provides evidence of its potential superiority over ONCAB. Moreover, the 
comparable sample size of the two groups (Table 3) in high OPCAB hospital volume setting 
underlies a neutral patient selection process which strength our conclusions.         
The association between surgical case volume and outcome after coronary artery bypass graft 
surgery has been extensively studied and have led to the development of guidelines by the 
American Heart Association/ American College of Cardiology [23] specifying the minimum 
number of procedures performed annually by cardiac surgeons. Based on our findings, future 
guidelines should include OPCAB high volume programs as they have the potential to reduce 
operative mortality. Low volume OPCAB hospital and surgeon should be discourage from 
undertaking multiple graft OPCAB surgery. 
Study Limitations 
This study has select limitations and considerations that deserve further discussion. As 
previously discussed, the inherent selection bias represented at the surgeon level for the 
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performance of OPCAB versus ONCAB must be considered in any such comparative analysis 
in particular in a low volume setting. Furthermore, conversion rate from OPCAB  to ONCAB 
is a well-known risk factor for hospital mortality [24] but it is not captured by NIS. However, 
surgeons with very low case volumes are more likely to convert OPCAB procedures to 
ONCAB compared to surgeons with high case volumes [24]. Therefore, such an inherent bias 
is likely to determine an underestimation of the detrimental effect of OPCAB over ONCAB  in 
case of low OPCAB volume. We used in-hospital mortality rate as the primary outcome 
measure. We were unable to obtain data on out of hospital deaths (eg, 30 days) which  would 
have been preferable. It would also have been desirable to include other risk-adjusted adverse 
outcome measures such as surgical complications. Although conditions like stroke (ICD-9-CM 
codes 997.02, 362.31, 368.12, 781.4, 433.11, 435, and 434) and acute renal failure (ICD-9-CM 
code 584) are reported in the NIS, it is not possible to discriminate if there were present on the 
admission or if they occurred after surgery and therefore, we decide not to include them in the 
analysis. Length of stay and total costs are unbiased secondary outcomes anticipated to be 
associated with postoperative complications rate and their association with the treatment effect 
across OPCAB volume quartiles supports our conclusion. Finally, the potential for 
unrecognized miscoding of diagnostic and procedure codes must be recognized in any 
secondary analysis of administrative data. Nevertheless, in the assessment of hospitals and 
surgeons volume and their effect on risk-adjusted mortality, the use of NIS provides great 
strength in its ability to capture a large, broadly generalizable patient population and surgeons 
with a great range of experience. As a result, these analyses provide important insight into an 
unanswered question regarding the influence of annual hospital and surgeon OPCAB and 
ONCAB volume on in hospital mortality, length of stay and costs. 
In conclusion, OPCAB surgery in high volume hospitals and surgeons reduces mortality 
compared to ONCAB surgery.  OPCAB surgery by low volume centres and surgeons should 
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be discouraged since it increases mortality when compared with ONCAB surgery.  Contrary to 
recent reports suggesting that OPCAB should be abandoned [3,8], our findings suggest that 
OPCAB programs should be maintained in selected high volume centres. Furthermore, 
OPCAB surgery adoption by institutions prepared to develop a proper programme, should be 
encouraged, given its potential to significantly lower mortality rates when compared with 
ONCAB surgery. 
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Table 1. Descriptive statistics for patients undergoing OPCAB and ONCAB  
 OPCAB ONCAB P-value 
 n=546,243 n=1,547,851  
Age (years) 65.4±0.1 65.0±0.1 0.0009 
Female 29.5% 26.7% <0.0001 
White 59.2% 61.6% 0.12 
Other than white 40.8% 38.4%  
Elective admission 45.2% 46.5% 0.11 
Single graft performed 20.6% 12.9% <0.0001 
Coexisting medical conditions    
Acquired immune deficiency syndrome (AIDS) 0.1% 0.1% 0.0004 
Alcohol abuse 2.6% 2.4% 0.18 
Chronic blood loss anaemia 1.3% 1.4% 0.26 
Chronic lung disease 22.4% 21.6% 0.06 
Coagulopathy 8.3% 9.9% <0.0001 
Congestive Heart Failure 1.3% 0.8% <0.0001 
Deficiency anaemia 15.8% 15.0% 0.31 
Depression 4.8% 4.7% 0.62 
Diabetes with chronic complication 5.6% 6.1% 0.03 
Drug abuse 1.0% 0.9% 0.04 
Fluid and electrolyte disorders 19.8% 18.8% 0.37 
Hypertension 69.9% 72.2% <0.0001 
Hypothyroidism 7.3% 7.3% 0.69 
Liver disease 1.0% 0.8% 0.0002 
Lymphoma  0.3% 0.3% 0.96 
Metastatic cancer 0.2% 0.1% <0.0001 
Obesity 13.5% 15.0% 0.01 
Other neurological disorders 2.7% 2.6% 0.22 
Paralysis 1.1% 1.1% 0.64 
Peptic ulcer disease excluding bleeding 0.3% 0.3% 0.92 
Peripheral vascular disease 13.7% 12.7% 0.02 
Psychosis 1.3% 1.3% 0.45 
Pulmonary circulation disorders 0.1% 0.1% 0.21 
Renal failure 10.0% 9.1% 0.001 
Rheumatoid arthritis/collagen vascular diseases 1.5% 1.5% 0.56 
Solid tumour without metastasis 1.1% 1.0% 0.01 
Uncomplicated Diabetes  29.3% 32.1% <0.0001 
Valvular disease 0.4% 0.3% <0.0001 
Weight loss 2.1% 1.7% 0.001 
Hospital-level variables    
Location   0.93 
    Urban  95.7% 95.7%  
    Rural  4.3% 4.3%  
Teaching Hospital    
    Yes  58.3% 57.5% 0.73 
    No  41.7% 42.5%  
Hospital bed size    
 16 
 
    Small 8.3% 6.5% 0.007 
    Medium 23.4% 17.3%  
    Large 68.3% 76.2%  
Operative Data    
Single graft 20.6% 12.9% <0.0001 
Previous CABG  1.3% 1.3% 0.85 
OPCAB: off-pump coronary artery bypass grafting; ONCAB: on-pump coronary artery 
bypass grafting 
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Table 2. Crude incidence of outcomes in OPCAB versus ONCAB according to OPCAB 
hospital volume  
OPCAB: off-pump coronary artery bypass grafting; ONCAB: on-pump coronary artery 
bypass grafting.   
  Overall 1st OPCAB 
HV quartile 
(<29/yr) 
2nd OPCAB 
HV quartile 
(29-81/yr) 
3rd OPCAB 
HV quartile 
(82-163/yr) 
4th OPCAB 
HV quartile 
(≥164/yr) 
 OPCAB(n)  546,243 48,120 107,202  145,026  245,895 
nONCAB(n)  1,547,851 488,261 410,176 380,913 268,502 
Mortality (%)       
OPCAB  2.5% 3.5% 3.0% 2.7% 2.1% 
ONCAB  2.0% 1.9% 1.9% 2.0% 2.2% 
ϰ2  P-value  <0.0001 <0.0001 <0.0001 <0.0001 0.73 
Hospital stay 
(days) 
      
OPCAB  9.6±0.13 10.9±0.17 10.3±0.16 9.6±0.15 9.2±0.24 
ONCAB  9.2±0.07 9.2±0.09 9.1±0.11 9.2±0.15 9.3±0.21 
ϰ2  P-value  0.0003 <0.0001 <0.0001 0.16 0.78 
Total costs ($)       
OPCAB  115,019±3,613 146,499±3,994 127,551±3980 112,495±4136 104,878±6,916 
ONCAB  110,721±2,326 124,110±3,843 108,852±4653 99,960±4052 103,547±5,869 
ϰ2  P-value  0.20 <0.0001 <0.0001 0.0004 0.81 
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Table 3. Risk-adjusted estimates for ONCAB versus OPCAB on outcomes according to 
OPCAB hospital volume (P<.05 in bold) 
  Overall 1st OPCAB 
HV quartile 
(<29/yr) 
2nd OPCAB 
HV quartile 
(29-81/yr) 
3rd OPCAB 
HV quartile 
(82-163/yr) 
4th OPCAB 
HV quartile 
(≥164/yr) 
OPCAB(n)  546,243 48,120 107,202 145,026 245,895 
ONCAB(n)  1,547,851 488,261 410,176 380,913 268,502 
Mortality (%)       
 model 
1 
1.04 
[0.94-1.14] 
1.30 
[1.11-1.51] 
1.16 
[0.99-1.37] 
1.07 
[0.93- 1.24] 
0.81 
[0.65-0.99] 
 model 
2 
1.02 
[0.93-1.12] 
1.29 
[1.10-1.50] 
1.11 
[0.95-1.30] 
1.02 
[0.88- 1.18] 
0.80 
[0.65-0.98] 
Hospital stay 
(days) 
      
 model 
1 
0.19±0.12 1.09±0.16 0.57±0.15 0.05±0.13 0.05±0.23 
 model 
2 
0.19±0.12 1.03±0.16 0.76±0.15 0.19± 0.12 0.20±0.23 
Total costs ($)       
 model 
1 
2063±3730 15,905±3824 12,848±4651 13,390±3313 2387±6258 
 model 
2 
-944±3659 11,823±3159 5630±3501 4025±2556 -4351±4598 
OPCAB: off-pump coronary artery bypass grafting; ONCAB: on-pump coronary artery 
bypass grafting 
model 1: clustered for ID Hospital + patient level variables including age, gender, race, elective 
admission and risk related to coexisting medical conditions  + hospital-level variables such as 
hospital region, location teaching status, and bed size; model 2: model 1 + ONCAB hospital 
volume + year of surgery 
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Table 4. Risk-adjusted estimates for OPCAB versus ONCAB on outcomes according to 
OPCAB surgeon volume (P<.05 in bold) 
OPCAB: off-pump coronary artery bypass grafting; ONCAB: on-pump coronary artery 
bypass grafting 
model 1: clustered for ID Hospital + patient level variables including age, gender, race, elective 
admission and risk related to coexisting medical conditions  + hospital-level variables such as 
hospital region, location teaching status, and bed size; model 2: model 1 + ON-CABG hospital 
volume + year of surgery 
  
  Overall 1st  
OPCAB 
SV quartile 
(<6/yr) 
2nd 
OPCAB 
SV quartile 
(6-18/yr) 
3rd 
OPCAB 
SV quartile 
(19-47/yr) 
4th 
OPCAB 
SV quartile 
(≥48yr) 
OPCAB  295,045 31,065 39,037 65,624 159,319 
ONCAB  729,827 241,540 206,588 187,573 94,126 
Mortality (%)       
 model 1 1.03 
[0.90-1.17] 
1.28 
[1.08- 1.53] 
1.30 
[ 1.08-1.56] 
1.28 
[1.08-1.51] 
0.64 
[0.51-0.80] 
 model 2 0.99 
[0.87-1.12] 
1.23 
[1.02-1.48] 
1.30 
[1.08-1.58] 
1.26 
[1.05-1.50] 
0.58 
[0.45-0.71] 
Hospital stay 
(days) 
      
 model 1 0.36±0.18 2.12±0.22 1.30±0.20 0.60±0.22 -0.16±0.22 
 model 2 0.31±0.17 1.76±0.21 1.37±0.20 0.73±0.22 -0.15±0.17 
Total costs ($)       
 model 1 5,534±4,597 28,480±4653 18,258±3803 13,028±3623 -9109±5229 
 model 2 1438±4463 20,773±4264 13,096±2902 5,886±3139 -10,778±4172 
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Table 5. Subgroup analyisis (hospital and surgeon volume) on primary outcome (in-hospital 
mortality) according to number of grafts performed (1 vesus ≥2 grafts) (P<.05 in bold) 
Analysis according 
to Hospital Volume 
Overall 1st  
OPCAB 
HV quartile 
(<29/yr) 
2nd  
OPCAB HV 
quartile 
(29-81/yr) 
3rd  
OPCAB HV 
quartile 
(82-163/yr) 
4th  
OPCAB HV 
quartile 
(≥164/yr) 
1 grafts      
   OPCAB(n) 112,587 10,861 22,852 31,032 47,843 
   ONCAB(n) 200,064 61,486 53,882 51,287 33,410 
Model 2 0.82 
[0.71-0.96] 
1.06 
[0.75-1.49] 
0.98 
[0.71- 1.36] 
0.70 
[0.52- 0.96] 
0.66 
[0.49-0.89] 
      
≥2 grafts       
   OPCAB(n) 433,655 37,259 84,350 113,994 198,052 
  ONCAB(n) 1,347,787 426,775 356,294 329,626 235,092 
Model 2 1.06 
[0.96-1.17] 
1.32 
[1.06-1.57] 
1.13 
[0.97-1.31] 
1.09 
[0.93-1.26] 
0.82 
[0.66- 0.99] 
      
      
Analysis according 
to Surgeon Volume 
Overall 1st  
OFF-CABG 
SV quartile 
(<6/yr) 
2nd  
OFF-CABG 
SV quartile 
(6-18/yr) 
3rd  
OFF-CABG  
SV quartile 
(19-47/yr) 
4th  
OFF-CABG 
SV quartile 
(≥48yr) 
1 graft      
   OPCAB (n) 60,702 6,566 9,338 14,315 30,483 
   ONCAB (n) 94,397 33,170 27,183 23,148 10,897 
Model 2 0.85 
[0.69-1.05] 
1.06 
[0.69-1.62] 
1.31 
[0.86-1.99] 
1.64 
[1.06-  2.53] 
0.33 
[0.22- 0.47] 
      
      
≥2 grafts      
   OPCAB (n) 234,344 24,500 29,700 51,309 128,836 
   ONCAB (n) 635,429 208,370 179,405 164,425 83,229 
  Model 2 1.007 
[0.88-1.15] 
1.26 
[1.03-1.53] 
1.26 
[1.02-1.56] 
1.21 
[0.99-1.47] 
0.63 
[0.49- 0.81] 
OPCAB: off-pump coronary artery bypass grafting; ONCAB: on-pump coronary artery 
bypass grafting 
Clustered for hospital ID and adjusted for patient level variables including age, gender, race, 
elective admission and risk related to coexisting medical conditions and hospital-level variables 
such as hospital region, location teaching status, and bed size. 
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Supplementary Figure 1. Total number  of OPCAB(red) and ONCAB(blue) procedures 
performed during the study period .  
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Figure 2. Number of OPCAB (red) and ONCAB (blue) procedures per centre (horizontals) 
ordered for OPCAB hospital volume (top) and OPCAB rate per centre (horizontals) ordered 
for total hospital volume (bottom)    
 
